BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7831291)

  • 1. Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.
    Natsoulis G; Seshaiah P; Federspiel MJ; Rein A; Hughes SH; Boeke JD
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):364-8. PubMed ID: 7831291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiviral strategy using capsid-nuclease fusion proteins.
    Natsoulis G; Boeke JD
    Nature; 1991 Aug; 352(6336):632-5. PubMed ID: 1650915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures.
    Schumann G; Qin L; Rein A; Natsoulis G; Boeke JD
    J Virol; 1996 Jul; 70(7):4329-37. PubMed ID: 8676455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions.
    Deminie CA; Emerman M
    J Virol; 1993 Nov; 67(11):6499-506. PubMed ID: 8411353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.
    Schumann G; Hermankova M; Cannon K; Mankowski JL; Boeke JD
    J Virol; 2001 Aug; 75(15):7030-41. PubMed ID: 11435583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread.
    VanBrocklin M; Ferris AL; Hughes SH; Federspiel MJ
    J Virol; 1997 Apr; 71(4):3312-8. PubMed ID: 9060701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation.
    Pang R; He DN; Zhou B; Liu K; Zhao J; Zhang XM; Chen PY
    Antiviral Res; 2013 Mar; 97(3):369-75. PubMed ID: 23321201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
    VanBrocklin M; Federspiel MJ
    Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures.
    Qin CF; Qin E; Yu M; Chen SP; Jiang T; Deng YQ; Duan HY; Zhao H
    Arch Virol; 2005 Apr; 150(4):659-69. PubMed ID: 15592886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of replication of classical swine fever virus in a stable cell line by the viral capsid and Staphylococcus aureus nuclease fusion protein.
    Zhou B; Liu K; Wei JC; Mao X; Chen PY
    J Virol Methods; 2010 Jul; 167(1):79-83. PubMed ID: 20304012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.
    Torrent C; Bordet T; Darlix JL
    J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of the replication of classical swine fever virus by capsid-targeted virus inactivation.
    Wang YF; Wang ZH; Li Y; Zhang XJ; Sun Y; Li M; Qiu HJ
    Antiviral Res; 2010 Feb; 85(2):422-4. PubMed ID: 19857524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of duck Tembusu virus capsid protein fused with staphylococcal nuclease protein to target Tembusu infection in vitro.
    Zhang X; Jia R; Pan Y; Wang M; Chen S; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Liu Y; Zhang L; Yin Z; Jing B; Huang J; Tian B; Pan L; Yu Y; Ur Rehman M; Cheng A
    Vet Microbiol; 2019 Aug; 235():295-300. PubMed ID: 31383316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Capsid-targeted viral inactivation for dengue virus infection].
    Qin CF; Jiang T; Chen SP; Yu M; Qin ED
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):111-5. PubMed ID: 15847175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral effect of a gag-RNase HI fusion gene.
    Schumann G; Cannon K; Ma WP; Crouch RJ; Boeke JD
    Gene Ther; 1997 Jun; 4(6):593-9. PubMed ID: 9231076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and manipulation of foamy virus membrane interactions.
    Swiersy A; Wiek C; Zentgraf H; Lindemann D
    Cell Microbiol; 2013 Feb; 15(2):227-36. PubMed ID: 23051660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of influenza RNA by using a human PUF-based artificial RNA-binding protein-staphylococcal nuclease hybrid.
    Mori T; Nakamura K; Masaoka K; Fujita Y; Morisada R; Mori K; Tobimatsu T; Sera T
    Biochem Biophys Res Commun; 2016 Oct; 479(4):736-740. PubMed ID: 27693585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant interference with hepatitis B virus replication by a core-nuclease fusion protein.
    Beterams G; Nassal M
    J Biol Chem; 2001 Mar; 276(12):8875-83. PubMed ID: 11124940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Gag mutation and processing on retroviral dimeric RNA maturation.
    Fu W; Dang Q; Nagashima K; Freed EO; Pathak VK; Hu WS
    J Virol; 2006 Feb; 80(3):1242-9. PubMed ID: 16415001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids.
    Beterams G; Böttcher B; Nassal M
    FEBS Lett; 2000 Sep; 481(2):169-76. PubMed ID: 10996318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.